You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hereditary Papillary Renal Cancer (HPRC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Kidney Cancer Trial run by the NCI (INC280)

Completed
  • Kidney Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 18, 2021

Von Hippel-Lindau: Clinical Manifestations, Diagnosis,

Recruiting
  • Kidney Cancer
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Hereditary Leiomyomatosis Renal Cell Cancer - Study of Genetic

    Recruiting
    • Renal Tumor Histology
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Dec 28, 2022

      Clear Cell Papillary Renal Tumor, Collecting Duct Carcinoma, Hereditary Leiomyomatosis and Renal Cell Carcinoma Trial in Los

      Recruiting
      • Clear Cell Papillary Renal Neoplasm
      • +10 more
      • Los Angeles, California
        UCLA / Jonsson Comprehensive Cancer Center
      Oct 25, 2021

      Kidney Cancer, Renal Cell Carcinoma, Clear Cell Carcinoma Trial in Dallas (13C-Glucose, 13C-Acetate, 13C-Lactate)

      Recruiting
      • Kidney Cancer
      • +11 more
      • 13C-Glucose
      • +4 more
      • Dallas, Texas
        University of Texas Southwestern Medical Center
      Dec 1, 2022

      Clear Cell Kidney Cancer, Kidney Cancer, Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations Trial (Axitinib 5 MG)

      Available
      • Clear Cell Kidney Cancer
      • +2 more
      • Axitinib 5 MG
      • (no location specified)
      Jul 3, 2023

      Metastatic Papillary Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 Trial (Atezolizumab, Cabozantinib S-malate)

      Recruiting
      • Metastatic Papillary Renal Cell Carcinoma
      • Stage IV Renal Cell Cancer AJCC v8
      • Atezolizumab
      • +4 more
      • Sacramento, California
      • +38 more
      Jan 17, 2023

      Advanced Clear Cell Renal Cell Carcinoma, Advanced Papillary Renal Cell Carcinoma, Advanced Renal Cell Carcinoma Trial in Duarte

      Recruiting
      • Advanced Clear Cell Renal Cell Carcinoma
      • +11 more
      • Cabozantinib S-malate
      • +2 more
      • Duarte, California
        City of Hope Medical Center
      Nov 22, 2022

      Renal Cell Carcinoma, Hereditary Leiomyomatosis, Renal Cell Cancer Trial run by the NCI (Vandetanib, Metformin,

      Terminated
      Has Results
      • Renal Cell Carcinoma
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Jan 12, 2021

      Hereditary Pancreatic Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Intraductal Papillary-Mucinous Tumor Trial in Portland

      Recruiting
      • Hereditary Pancreatic Carcinoma
      • +2 more
      • Dynamic Contrast-Enhanced Magnetic Resonance Imaging
      • Ferumoxytol
      • Portland, Oregon
        OHSU Knight Cancer Institute
      Aug 16, 2022

      Serum and Tissue Samples From Biopsy-Proved or Suspected

      Recruiting
      • Malignant Neoplasms
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 21, 2023

        Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Type 1, Papillary Renal Cell Carcinoma Type 2 Trial in Australia

        Recruiting
        • Renal Cell Carcinoma
        • +5 more
        • Albury, New South Wales, Australia
        • +10 more
        Feb 14, 2022

        oncRNA Stratification of Cancer by Size and Stage

        Not yet recruiting
        • Kidney Cancer
        • +32 more
        • Exai oncRNA blood test
        • (no location specified)
        Apr 27, 2023

        Advanced Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in United States (drug,

        Recruiting
        • Advanced Renal Cell Carcinoma
        • +8 more
        • Cabozantinib S-malate
        • +3 more
        • Birmingham, Alabama
        • +35 more
        Jan 24, 2023

        Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Type 1, Papillary Renal Cell Carcinoma Type 2 Trial in Australia

        Active, not recruiting
        • Renal Cell Carcinoma
        • +5 more
        • Albury, New South Wales, Australia
        • +18 more
        Feb 14, 2022

        Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma, Unclassified Renal Cell Carcinoma, Papillary Renal Cell Carcinoma

        Recruiting
        • Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma
        • +6 more
        • Basking Ridge, New Jersey
        • +6 more
        Feb 2, 2022

        Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis Trial in Bristol

        Recruiting
        • Adenine Phosphoribosyltransferase Deficiency
        • +83 more
          • Bristol, South West, United Kingdom
            Zoe Plummer
          Sep 26, 2023

          Kidney Cancer Trial in France (sunitinib malate)

          Completed
          • Kidney Cancer
          • sunitinib malate
          • Angers, France
          • +21 more
          Feb 18, 2021

          Carcinoma, Renal Cell, Renal Cell Carcinoma of Papillary Histology, Renal Cell Carcinoma With Clear Cell Histology Trial in

          Completed
          • Carcinoma, Renal Cell
          • +3 more
          • Ann Arbor, Michigan
          • +8 more
          Dec 16, 2020

          Papillary Renal Cell Cancer Trial in Worldwide (AZD6094)

          Completed
          Has Results
          • Papillary Renal Cell Cancer
          • Birmingham, Alabama
          • +22 more
          Mar 23, 2021

          Biomarkers of Renal Cancer

          Recruiting
          • Renal Cell Carcinoma
          • +3 more
            • Firenze, Italy
            • +3 more
            Mar 14, 2023

            Von Hippel-Lindau Disease, Hereditary Leiomyomatosis and Renal Cell Cancer, Birt-Hogg-Dube Syndrome Trial in Boston

            Recruiting
            • Von Hippel-Lindau Disease
            • +3 more
              • Boston, Massachusetts
                VHL Alliance
              Oct 4, 2021

              Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)

              Not yet recruiting
              • Papillary Renal Cell Carcinoma
              • (no location specified)
              Nov 24, 2023

              Carcinoma, Renal Cell Trial (Orellanine)

              Not yet recruiting
              • Carcinoma, Renal Cell
              • (no location specified)
              Jan 25, 2023

              Advanced Clear Cell Renal Carcinoma (Ccrcc), Papillary Renal Cell Carcinoma (Prcc) Trial run by the National Cancer Institute

              Not yet recruiting
              • Advanced Clear Cell Renal Carcinoma (Ccrcc)
              • Papillary Renal Cell Carcinoma (Prcc)
              • Bethesda, Maryland
                National Institutes of Health Clinical Center
              Feb 2, 2023